6-Mercaptopurine
6-Mercaptopurine is a pharmaceutical drug with 25 clinical trials. Currently 8 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
14
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
10 of 12 finished
16.7%
2 ended early
8
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Clinical Trials (25)
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia
Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25